Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland.
BACKGROUND
Major depressive disorder (MDD) has shown to cause high costs to society. Earlier research indicates that generalized anxiety disorder (GAD) also causes high costs, but only limited data is available in varying settings.


OBJECTIVE
To analyse the secondary care costs of GAD compared with those of MDD.


METHODS
Retrospective database analysis from Finnish Hospital Discharge Registers (FHDR). All GAD and MDD patients diagnosed between 1 January 2007 and 31 December 2007 in FHDR were recorded and individual-level secondary care costs during a 48-month follow-up period were measured.


RESULTS
The total mean cost of GAD with history of MDD or some other anxiety disorder was significantly higher than that of MDD with history of GAD or some other anxiety disorder during the 48-month follow-up period. The costs of pure GAD were comparable with those of pure MDD, but after adjusting for age and sex, the costs of pure MDD were higher than those of pure GAD.


CONCLUSIONS
The economic burden of individual GAD patients is comparable with that of MDD patients in secondary care.
Tero Kujanpää, postgraduate student, University of Oulu, Institute of Health Sciences , FIN-90014 Oulu , Finland.
Tero
T
Kujanpää
Tero
T
Ylisaukko-Oja
Jari
J
Jokelainen
Miika
M
Linna
Markku
M
Timonen
D000328:Adult; D001008:Anxiety Disorders / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D005260:Female; D005387:Finland / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006302:Health Services Research / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D012189:Retrospective Studies; D063127:Secondary Health Care / Q000191:economics*; D055815:Young Adult
Anxiety disorders; comorbidity; cost analysis; generalized anxiety disorder; major depressive disorder